Dressings Patents (Class 424/445)
-
Patent number: 7371403Abstract: This invention is directed to advanced hemorrhage control wound dressings, and methods of using and producing same. The subject wound dressing is constructed from a non-mammalian material for control of severe bleeding. The wound dressing for controlling severe bleeding is formed of a biomaterial comprising chitosan, a hydrophilic polymer, a polyacrylic polymer or a combination thereof. The kind of severe, life-threatening bleeding contemplated by this invention is typically of the type not capable of being stanched when a conventional gauze wound dressing is applied with conventional pressure to the subject wound. The wound dressing being capable of substantially stanching the flow of the severe life-threatening bleeding from the wound by adhering to the wound site, to seal the wound, to accelerate blood clot formation at the wound site, to reinforce clot formation at the wound site and prevent bleed out from the wound site, and to substantially prohibit the flow of blood out of the wound site.Type: GrantFiled: December 23, 2003Date of Patent: May 13, 2008Assignees: Providence Health System-OregonInventors: Simon J. McCarthy, Kenton W. Gregory, William P. Wiesmann, Todd D. Campbell
-
Patent number: 7368127Abstract: Biomedical devices with stable peptide coatings are provided. The coatings are formed by incorporating at least one latent reactive component into the reactive mixture, forming a medical device from said reactive mixture and reacting said medical device with a coating effective amount of a coating peptide to bond said coating to the surface by ester or amide linkages.Type: GrantFiled: December 19, 2002Date of Patent: May 6, 2008Assignee: Johnson & Johnson Vision Care, Inc.Inventor: Zanini Diana
-
Patent number: 7368128Abstract: A dressing for debridement of necrotic and non-viable tissue in a wound, wherein the dressing comprises an effective amount of one or more proteolytic enzymes incorporated in a degradable polymeric material. The dressing of the invention provides effective debridement of necrotic wounds over a prolonged period of time, as the enzymes may be released over time. As the enzymes are incorporated in the polymeric material, a high stability is achieved.Type: GrantFiled: October 8, 2004Date of Patent: May 6, 2008Assignee: Coloplast A/SInventor: Michael H. Qvist
-
Publication number: 20080095830Abstract: The present invention is directed to a method of making a dressing having at least one protein, comprising the steps of applying at least one protein to a dressing via conventional means; and further subjecting the dressing having the protein thereon to pressure ranging from about 2,500 to about 39,500 psi for about 2 to about 6 seconds.Type: ApplicationFiled: October 20, 2006Publication date: April 24, 2008Inventor: Robert W. Van Holten
-
Patent number: 7361634Abstract: The invention provides a wound dressing comprising a therapeutic agent and a matrix comprising polymers joined by cross-linkages which cross-linkages comprise oligopeptidic sequences which are cleavable by a kallikrein associated with wound fluid such that the rate of release of the therapeutic agent increases in the presence of elevated kallikrein levels.Type: GrantFiled: April 27, 2004Date of Patent: April 22, 2008Assignee: Ethicon, Inc.Inventors: Patrick J. Trotter, Breda M. Cullen
-
Publication number: 20080085300Abstract: A composition for promoting hemostasis is defined by a substrate in particle or pellet form and a hemostatic agent disposed on the substrate such that when using the composition to treat a bleeding wound, contacting the bleeding wound with the hemostatic agent causes blood to clot. The hemostatic agent may be a zeolite, bioactive glass, siliceous oxide, clay, biological hemostatic material, diatomaceous earth, or a combination of the foregoing. The substrate may be clay, glass, bioactive glass, diatomaceous earth, wax, polymer, plastic, metal, or a combination of the foregoing. A method of fabricating a hemostatic composition includes providing a substrate and a material having hemostatic characteristics. The hemostatic composition is fabricated by providing a material to operate as a carrier for the hemostatic material. The material is formed into particles or pellets. The material having hemostatic properties is applied or coated onto the particles of the carrier material.Type: ApplicationFiled: October 6, 2006Publication date: April 10, 2008Applicant: Z-Medica CorporationInventors: Raymond J. Huey, Denny Lo
-
Patent number: 7351426Abstract: This invention addresses absorbable cyanoacrylate-based tissue adhesive compositions based primarily on an alkoxy cyanoacrylate combined with one or more alkyl cyanoacrylate(s), a stabilizer against premature anionic polymerization, and/or an absorbable polymeric modifier with improved, and preferably, functional properties for use, primarily, for internal wound repair applications.Type: GrantFiled: March 3, 2004Date of Patent: April 1, 2008Assignee: Poly-Med, Inc.Inventors: Shalaby W. Shalaby, M. Aaron Vaughn
-
Publication number: 20080063696Abstract: A transcutaneous immunization system where the topical application of an adjuvant and an antigen or nucleic acid encoding for an antigen, to intact skin induces a systemic or mucosol antibody response. The immune response so elicited can be enhanced by physical or chemical skin penetration enhancement.Type: ApplicationFiled: March 3, 2004Publication date: March 13, 2008Inventors: Gregory M. Glenn, Carl R. Alving
-
Publication number: 20080063697Abstract: It is known that activated and partially activated zeolites are effective in hemostasis. However, the use of fully hydrated, unactivated zeolites has been ignored up to this point based upon a belief that it was necessary for such zeolites to concentrate certain components in the blood by removal of water. It has now been found that fully hydrated zeolites clot blood almost as quickly as fully activated zeolites that have been dehydrated without the potentially injurious exothermic response which may cause burns in tha case of fully activated zeolites.Type: ApplicationFiled: September 8, 2006Publication date: March 13, 2008Inventor: Robert L. Bedard
-
Patent number: 7335376Abstract: The present invention relates to medicine, more concretely to photodynamic therapy, and may be used in oncology and dermatology. A method is proposed for photodynamic therapy of pathological surface formations, which comprises sensitizing a surface of the pathological area by superposing an applicator containing 5-aminolevulinic acid, and irradiating the sensitized area with therapeutic optical radiation in the spectral range of 625-700 nm, wherewith an applicator is used which is transparent in the spectral range of at least 625-700 nm, and irradiation is carried out through the applicator. Wherewith therapeutic irradiation is carried out under control of the intensity of fluorescence of the tissues of the pathological area by irradiation of the tissues in the spectral range of 625-635 nm and measurement of the intensity of fluorescence in the range of 635-700 nm through the applicator.Type: GrantFiled: January 11, 2002Date of Patent: February 26, 2008Assignee: Federalnoe Gosudarstvennoe Unitarnoe Predpriyatie “Gosudarstvenny Nauchny Tsentr Nauchno-Issledovatelsky Institut Organicheskikh Poluproduktov I Krasitelei” (FGUP “GNTTS NIOPIK”)Inventors: Georgy Nikolaevich Vorozhtsov, Anatoly Borisovich Davydov, Sergei Georgievich Kuzmin, Viktor Borisovich Loschenov, Yury Mikhailovich Luzhkov, Evgeny Antonovich Lukyanets, Gennady Alexandrovich Meerovich, Gennady Lvovich Khromov
-
Publication number: 20080038327Abstract: The invention relates to a would care product that provides a biochemical environment around a wound to promote wound healing. The wound care product includes a keratin protein fraction material in which the protein fraction is intact, is from the intermediate filament protein family or the high sulfur protein family and in which the protein fraction is S-sulfonated. The invention also described a method of making a wound care product.Type: ApplicationFiled: December 16, 2004Publication date: February 14, 2008Inventors: Robert James Kelly, Alisa Dawn Roddick-Lanzilotta, Mohammad Azam Ali
-
Patent number: 7329417Abstract: A medical dressing comprising a complex of silver and being capable of releasing antimicrobial silver ion activity, the complex comprising silver ion, a transition element of Group IV of the periodic system of elements, cation, phosphate and hydrogen to enable a controlled release of silver ion activity to a wound bed.Type: GrantFiled: February 8, 2002Date of Patent: February 12, 2008Assignee: Coloplast A/SInventor: Brian Nielsen
-
Publication number: 20080003244Abstract: The invention provides, in one embodiment, a method for making lecithin phospholipid with lipoic or piperic acid based composition, a preparation for use as a topical skin application for treatment of infectious skin lesions such as acne, for the protection of skin cells from oxidative agents, and as anti-inflammatory treatments.Type: ApplicationFiled: June 28, 2007Publication date: January 3, 2008Inventor: Gary Viole
-
Patent number: 7309498Abstract: A biodegradable microfiber absorbent comprises a substantially homogeneous mixture of at least one hydrophilic polymer and at least one biodegradable polymer. The absorbent can be prepared by an electro hydrodynamic spinning of a substantially homogeneous polymer mixture. Medical dressings for burns and wounds, cavity dressings, drug delivery patches, face masks, implants, drug carriers that comprises at least one microfiber electrospun from a polymer mixture are provided. The dressings can have variable water vapor penetration characteristics and variable biodegradation times.Type: GrantFiled: October 9, 2002Date of Patent: December 18, 2007Inventors: Bronislava G. Belenkaya, Valentina I. Sakharova, Vyacheslav N. Polevov
-
Publication number: 20070275042Abstract: A curable composition is described, including a gel material derived from the curable composition, and medical articles including such material, wherein the transparent gel material includes a polymerized monofunctional poly(alkylene oxide) macromonomer component and a surface modified nanoparticle component.Type: ApplicationFiled: May 23, 2006Publication date: November 29, 2007Inventors: Kelly S. ANDERSON, Kevin M. LEWANDOWSKI, David J. PLAUT, Wendy L. THOMPSON, Babu N. GADDAM
-
Patent number: 7300663Abstract: Proteinaceous polymers having repetitive units from naturally occurring structural proteins are employed as backbones for functionalities for crosslinking to provide strongly adherent tissue adhesives and sealants. Particularly, block copolymers of elastin and fibroin are employed having lysine substitutions in spaced apart units, where the amino group can be crosslinked using difunctional crosslinking agents.Type: GrantFiled: April 5, 2002Date of Patent: November 27, 2007Assignee: Protein Polymer Technologies, Inc.Inventors: Erwin R. Stedronsky, Joseph Cappello
-
Patent number: 7300673Abstract: Methods for the production of deposition products including an oxidized metal species under both acidic and alkaline conditions, methods for the production of composite materials including a substrate and the deposition product, and products in the nature of deposition products and composite materials. The methods are particularly suited for depositing a very thin layer of a deposition product on a substrate and may be used to produce composite materials for use in many applications, including but not limited to electronics, materials engineering and medical applications. In a preferred embodiment, the metal is silver, the substrates are medical devices or components of medical devices and the deposition product includes an antimicrobially active oxidized silver species.Type: GrantFiled: April 23, 2004Date of Patent: November 27, 2007Assignee: Exciton Technologies Inc.Inventor: Stojan Djokic
-
Patent number: 7297343Abstract: A wound dressing, method of making, and method of use, utilizing a polymeric film having complexed thereto by hydrophobic interaction a construct including a polyanion covalently bonded to a hydrophobic prosthetic moiety, with one or more bioactive molecules directly complexed to the polyanion. The polyanion may be heparin or a heparin-activity molecule. The prosthetic group may include a hydrophobic silyl-containing moiety. Bioactive molecules include adhesive molecules, growth factor molecules, and therapeutic molecules, including antibiotics.Type: GrantFiled: October 10, 2003Date of Patent: November 20, 2007Assignee: BioSurface Engineering Technologies, Inc.Inventor: Paul O. Zamora
-
Publication number: 20070264315Abstract: The present invention relates to a biocompatible paste containing an aqueous excipient which can be used to form a dressing by the application of said paste to the oral mucosae or the skin, containing the following as essential constituents: natural kaolin containing at least 80% by weight, preferably at least 95% by weight, of kaolinite; a humectant selected from the group consisting of propylene glycol, glycerol, polyethylene glycol, sorbitol and mixtures thereof; and a hydrogelling agent forming a hydrogel with part of the water present in said excipient, which is selected from the group consisting of anhydrous colloidal silica, cellulose, carboxymethyl cellulose, guar gum, xanthan gum and mixtures thereof. It further relates to a method of stopping the oral mucosae or the skin from bleeding, by applying said paste in efficient amount to form a dressing, especially a hemostatic dressing.Type: ApplicationFiled: April 18, 2007Publication date: November 15, 2007Applicant: PRODUITS DENTAIRES PIERRE ROLLANDInventors: Marguerite FOURNIE, Patrick LESAGE
-
Patent number: 7291762Abstract: A dressing for promoting healing and pain relief of the body of a living organism having a pathologic condition has at least one layer of conductive material having a resistance no greater than 1000 ?/cm2. When placed proximate a portion of the body of the living organism suffering from the pathologic condition, the dressing alters the electrodynamic processes occurring in conjunction with said pathologic condition to promote healing and pain relief in the living organism. When used as a wound dressing, the conductive material is placed in contact with tissue around the periphery of the wound and with the wound, lowering the electrical potential and resistance of the wound and increasing the wound current. In an exemplary embodiment, the conductive material is a multi-ply nylon fabric plated with silver by an autocatalytic electroless plating process and with the plies in electrical continuity. The dressing provides an antimicrobial and analgesic effect.Type: GrantFiled: September 11, 2003Date of Patent: November 6, 2007Assignee: Argentum International, LLCInventor: A. Bart Flick
-
Patent number: 7282214Abstract: Biomedical devices with antimicrobial coatings are provided. One or more surfaces of the device are coated with a cationic peptide, cationic proteins, or mixtures thereof to impart antimicrobial properties to the surface.Type: GrantFiled: December 19, 2002Date of Patent: October 16, 2007Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Mark Willcox, Emma Hume, Nerida Cole, Yulina Aliwarga, Zanini Diana
-
Patent number: 7279177Abstract: The present invention is directed to a hemostatic wound dressing that utilizes a fibrous, fabric substrate made from carboxylic-oxidized cellulose and containing a first surface and a second surface opposing the first surface, the fabric having flexibility, strength and porosity effective for use as a hemostat; and further having a porous, polymeric matrix substantially homogeneously distributed on the first and second surfaces and through the fabric, the porous, polymeric matrix being made of a biocompatible, water-soluble or water-swellable cellulose polymer, wherein prior to distribution of the polymeric matrix on and through the fabric, the fabric contains about 3 percent by weight or more of water-soluble oligosaccharides.Type: GrantFiled: March 25, 2003Date of Patent: October 9, 2007Assignee: Ethicon, Inc.Inventors: Dwayne Lee Looney, Jian Xin Guo, Guanghui Zhang, Sanyog Manohar Pendharkar, Anne Jessica Gorman, Thomas Lee Craven, Michelle Bermel
-
Patent number: 7276247Abstract: The present invention provides crosslinkable compositions useful in the preparation of hydrophilic gels, and are prepared from oligomers having pendent hydrophilic, poly(alkylene oxide) groups, pendent photoinitiator groups, and optionally polymerizable functional groups, and crosslinked by polyfunctional poly(alkylene oxides).Type: GrantFiled: April 11, 2006Date of Patent: October 2, 2007Assignee: 3M Innovative Properties CompanyInventors: Duane D. Fansler, Kevin M. Lewandowski, Michael S. Wendland, Babu N. Gaddam, Steven M. Heilmann
-
Patent number: 7270834Abstract: A pharmaceutical composition to be externally applied as a topical preparation for treating several diseases, the composition comprising dimethylsulfoxide (DMSO) and ozone. A method for obtaining the composition by ozonizing DMSO and a method for treating diseases by applying the composition are also provided.Type: GrantFiled: June 3, 2002Date of Patent: September 18, 2007Inventors: Haydee Alba Stenti, Claudia Pirillo, Jose Maria Pastoriza
-
Patent number: 7264823Abstract: An adhesive including a mixture of isocyanate capped molecules formed by reacting multi-isocyanate functional molecules with multi-functional precursor molecules including terminal functional groups selected from the group consisting of a hydroxyl group, a primary amino group and a secondary amino group. Preferably, the functional groups are hydroxyl groups. The multi-functional precursor compounds are biocompatible. Multi-amine functional precursors of the multi-isocyanate functional molecules are also biocompatible. As discussed, above, the mixture of molecules preferably has an average isocyanate functionality of at least 2.1 and, more preferably, has an average isocyanate functionality of at least 2.5. As also described above, the mixture of molecules preferably has a viscosity in the range of approximately 1 to approximately 100 centipoise. The mixture of molecules forms a crosslinked polymer network upon contact with the organic tissue in the presence of water.Type: GrantFiled: February 10, 2003Date of Patent: September 4, 2007Assignee: University of PittsburghInventors: Eric J. Beckman, Michael Buckley, Sudha Agarwal, Jianying Zhang
-
Publication number: 20070185463Abstract: A wound dressing system includes a fluid permeable support member for positioning within a wound and adapted to generally conform to a topography of a wound, a plurality of beads supported by the support member, an outer member for positioning over the wound to substantially enclose the beads and a conduit for supplying reduced pressure to the wound. The support member is adapted to permit exudates from the wound to pass therethrough. The beads are characterized by having sufficient rigidity to substantially maintain respective shapes thereof to thereby facilitate passage of the exudates through spaces or passages defined between adjacent beads. The beads may comprise glass, an acrylic or a polymeric material. The support member may comprise a polymeric or fabric material. The support member may be an enclosure member or pouch which houses the beads. Multiple pouches are also envisioned.Type: ApplicationFiled: February 6, 2007Publication date: August 9, 2007Inventor: Sharon Mulligan
-
Patent number: 7252837Abstract: The present invention is directed to wound dressings that contain a fabric made from biocompatible polymeric fibers and having flexibility, strength and porosity effective for use as a hemostat, and a porous, polymeric matrix prepared from a biocompatible, water-soluble or water-swellable polymer dispersed through the fabric; and to methods of making such wound dressings.Type: GrantFiled: June 28, 2002Date of Patent: August 7, 2007Assignee: Ethicon, Inc.Inventors: Jian Xin Guo, Dwayne Lee Looney, Guanghui Zhang, Anne Jessica Gorman
-
Patent number: 7244447Abstract: A method is provided for increasing the permeability of skin or mucosal tissue to transdermally administered nonsteroidal anti-inflammatory drugs (NSAIDs). The method involves use of a specified amount of a hydroxide-releasing agent, the amount optimized to increase the flux of the NSAID through a body surface while minimizing the likelihood of skin damage, irritation or sensitization. Formulations and drug delivery systems for co-administering a hydroxide-releasing agent with an NSAID are provided as well.Type: GrantFiled: July 30, 2003Date of Patent: July 17, 2007Assignee: Dermatrends, Inc.Inventors: Tsung-Min Hsu, Eric C. Luo
-
Patent number: 7235263Abstract: Processes for preparing products comprising an oxygen-generating additive for reducing the amount of skin irritation and inflamation and odor are disclosed. Specifically, products such as training pants and diapers are disclosed which contain a carbohydrate-hydrogen peroxide crystalline powder which, when wetted, produces a stream of oxygen which can be used by various bacteria on and near the wearer's skin during metabolism resulting in a significant decrease in the amount of volatile organic compounds produced by the bacteria during metabolism.Type: GrantFiled: February 10, 2005Date of Patent: June 26, 2007Assignee: Kimberly-Clark Worldwide, Inc.Inventors: David William Koenig, Bernard J. Minerath, Lindsay M. Gould
-
Patent number: 7223418Abstract: A stretch plaster comprising a support membrane having a thickness of 1 to 50 ?m and a drug containing adhesive layer having a thickness of 3 to 400 ?m, wherein (i) the support membrane comprising a copolymer of 0 to 90% by weight of vinyl acetate, 10 to 97% by weight of alkyl (meth)acrylate having 3 to 14 of a mean carbon number of alkyl group and 0 to 15% by weight of (meth)acrylic acid, (ii) the copolymer is cross-linked by polyvalent metal such as aluminum or a poly-functional chain compound, wherein the cross-linking ratio is 20% or more of the theoretical total number of carboxyl group of the copolymer when the polymer is cross-linked by the polyvalent metal such as aluminum, and is 1 to 10% expressed by copolymerized ratio of the poly-functional chain compound when the copolymer is cross-linked by poly-functional chain compound, (iii) the support membrane has 150 g or less of self adhesion shown by an adhesion between the support membranes and (iv) the support membrane has 70% or more of an elasticitType: GrantFiled: March 5, 2001Date of Patent: May 29, 2007Assignee: Tiejin LimitedInventors: Osafumi Hidaka, Akiko Ohata
-
Patent number: 7189410Abstract: This invention provides a fibrin sealant bandage, wherein said fibrin sealant may be supplemented with at least one composition selected from, for example, one or more regulatory compounds, antibody, antimicrobial compositions, analgesics, anticoagulants, antiproliferatives, anti-inflammatory compounds, cytokines, cytotoxins, drugs, growth factors, interferons, hormones, lipids, demineralized bone or bone morphogenetic proteins, cartilage inducing factors, oligonucleotides polymers, polysaccharides, polypeptides, protease inhibitors, vasoconstrictors or vasodilators, vitamins, minerals, stabilizers and the like. Also disclosed are methods of preparing and/or using the unsupplemented or supplemented fibrin sealant bandage.Type: GrantFiled: June 7, 1995Date of Patent: March 13, 2007Assignee: The American National Red CrossInventors: William N. Drohan, Martin J. MacPhee, Wilson H. Burgess, Hernan Nunez, Manish Singh, Gene Liau, Thomas Maciag
-
Patent number: 7176256Abstract: Crosslinked polymer compositions comprise a first synthetic polymer containing multiple nucleophilic groups covalently bound to a second synthetic polymer containing multiple electrophilic groups. The first synthetic polymer is preferably a synthetic polypeptide or a polyethylene glycol that has been modified to contain multiple nucleophilic groups, such as primary amino (—NH2)or thiol (—SH) groups. The second synthetic polymer may be a hydrophilic or hydrophobic synthetic polymer which contains, or has been derivatized to contain, two or more electrophilic groups, such as succinimidyl groups. The compositions may further comprise other components, such as naturally occurring polysaccharides or proteins (such as glycosaminoglycans or collagen) and/or biologically active agents.Type: GrantFiled: June 21, 2004Date of Patent: February 13, 2007Assignee: Angiotech Pharmaceuticals (US), Inc.Inventors: Woonza M. Rhee, Frank A. DeLustro, Richard A. Berg
-
Patent number: 7147845Abstract: The present invention relates to novel antimicrobial silver ion complex resinates. More particularly, the present invention contemplates silver ion complex resinate compositions comprising a silver-thiosulfate ion complex loaded onto an organic anion exchange resin. These silver thiosulfate ion complex resinate compositions are able to release stable antimicrobial silver ion complexes when placed in a saline environment. These antimicrobial silver-ion complex resinates are useful in the treatment and prevention of infections and diseases.Type: GrantFiled: April 14, 2004Date of Patent: December 12, 2006Assignee: BioInterface Technologies, Inc.Inventor: Christopher C. Capelli
-
Patent number: 7128929Abstract: The specification discloses an alginate foam composition dressing which may be prepared with or without a backing. The foam dressing exhibits unique capability in including soluble or insoluble medicaments as part of the alginate foam composition, attributes not inherent in alginate dressings prepared by spinning. The dressings so prepared also eliminate the need for adhesives and secondary dressings for retaining an alginate dressing on a wound site.Type: GrantFiled: October 2, 2000Date of Patent: October 31, 2006Inventor: George H. Scherr
-
Patent number: 7118761Abstract: Wound care devices having a topically applied silver-based antimicrobial finish are provided. The finish comprises at least one silver ion-containing compound and at least one binder compound. The finish may be applied to a target substrate, such as a fiber, fabric, film, foam, hydrogel, or hydrocolloid to provide a single layer antimicrobial wound care device. Alternatively, a silver-containing layer may be combined with one or more additional layers of target substrate to provide a composite antimicrobial wound care device. The device may also contain an odor-absorbing component capable of reducing or eliminating odors that are inherently associated with infectious wounds. Also provided is a method for making the wound care device and a composition of matter comprising the silver-based antimicrobial finish.Type: GrantFiled: August 14, 2003Date of Patent: October 10, 2006Inventors: T. Andrew Canada, Robert L. Schuette, Raymond C. Sturm, Kenneth M. Wiencek, Jason L. Kreider
-
Patent number: 7115276Abstract: The present invention refers to a flat self-adhering plaster having a multi-layer construction and reduced cold flow, characterized in that the layer of adhesive possesses a core of adhesive being a flowable adhesive and a ring of adhesive being an adhesive having reduced flowability which surrounds the core.Type: GrantFiled: June 23, 2000Date of Patent: October 3, 2006Assignee: Novosis AGInventors: Wilfried Fischer, Hubert Kaffl, Petra Huber, Clifton Zimmermann
-
Patent number: 7112334Abstract: Allergen contact with a person's allergen-responsive tissues is reduced by removing airborne allergens from body surfaces adjacent the person's eyes. Airborne allergens may be removed from body surfaces adjacent the person's eyes by irrigating such areas with an irrigating fluid or by wiping such areas with a pad. Preferably the irrigating fluid or the pad is treated to augment its effectiveness in removing airborne allergens or otherwise preventing them from entering the eye, and/or to reduce allergy symptoms in the eye area caused by airborne allergens that enter the eye.Type: GrantFiled: March 26, 2002Date of Patent: September 26, 2006Inventor: Roberta C. Freiberg
-
Patent number: 7105177Abstract: Diapers and wet wipes for cleansing of infants are made anti-bacterial by the inclusion therein of hop acid derivatives, specifically tetrahydroiso-alpha acid and hexahydro-beta acid. These compounds are effective to inhibit the growth of gram-positive bacteria, and specifically chosen to combat Staphylococcus aureus, a primary factor in toxic shock syndrome in infants.Type: GrantFiled: October 20, 2000Date of Patent: September 12, 2006Assignee: Miller Brewing CompanyInventors: Michael C. Barney, Alfonso Navarro, David S. Ryder
-
Patent number: 7101857Abstract: A method for promoting angiogenesis in a patient comprising providing crosslinkable biological solution to the target tissue, wherein the crosslinkable biological solution is loaded with at least one angiogenic agent. In one embodiment, the at least one angiogenic agent is a non-protein factor selected from a group consisting of ginsenoside Rg1, ginsenoside Re, combination thereof and the like. In another embodiment, the crosslinkable biological solution of the present invention is broadly defined in a form or phase of solution, paste, gel, suspension, colloid or plasma that may be solidifiable thereafter.Type: GrantFiled: April 19, 2004Date of Patent: September 5, 2006Assignee: GP Medical, Inc.Inventors: Hsing-Wen Sung, Huang-chien Liang, Hosheng Tu
-
Patent number: 7101862Abstract: The invention provides hemostatic compositions useful to promote hemostasis at active bleeding wound sites. The hemostatic compositions typically include an article containing cellulose, e.g., cotton gauze, and a polysaccharide covalently linked to the cellulose, or a polysaccharide ionically cross-linked and in association with the article. Methods of making and using the hemostatic compositions are also provided.Type: GrantFiled: December 31, 2002Date of Patent: September 5, 2006Assignee: Area Laboratories, LLCInventors: Kent C. Cochrum, Susan Jemtrud
-
Patent number: 7094428Abstract: A hemostatic composition which comprises at least one procoagulant metal ion, such as silver (I) or mercury (II), and at least one procoagulant biopolymer, such as collagen, thrombin, prothrombin, fibrin, fibrinogen, heparinase, Factor VIIa, Factor VIII, Factor IXa, Factor Xa, Factor XII, von Willebrand Factor, a selectin, a procoagulant venom, a plasminogen activator inhibitor, glycoprotein IIb-IIIa, a protease, or plasma. The composition in the form of a paste, dough, glue, liquid, lyophilized powder or foam, may be provided, for application to a wound. A hemostatic device is also described which comprises a hemostatic composition as described above. The device may be in the form of, for example, a plug, bandage, gauze, cloth, tampon, membrane or sponge. Methods are also provided for prophylaxis or treatment of bleeding at a site by application to the site of the composition or device as described.Type: GrantFiled: December 10, 2002Date of Patent: August 22, 2006Assignee: The University of Medicine and Dentistry of New JerseyInventors: Charles R. Spillert, Marcelle Khalil
-
Patent number: 7094418Abstract: A crosslinkable macromer system and related methods of preparing the system and using the system in the form of a crosslinked matrix between a tissue site and an implant article such as a tissue implant or on the porous surface of a prosthetic device. The macromer system includes two or more polymer-pendent polymerizable groups and one or more initiator groups (e.g., polymer-pendent initiator groups). The polymerizable groups and the initiator group(s), when polymer-pendent, can be pendent on the same or different polymeric backbones. The macromer system provides advantages over the use of polymerizable macromers and separate, low molecular weight initiators, including advantages with respect to such properties as nontoxicity, efficiency, and solubility. A macromer system of the invention can be used as an interface between the tissue site and implant article in a manner sufficient to permit tissue growth through the crosslinked matrix and between the tissue site and implant.Type: GrantFiled: November 17, 2004Date of Patent: August 22, 2006Assignee: SurModics, Inc.Inventors: Stephen J. Chudzik, David L. Clapper
-
Patent number: 7076282Abstract: Bioadhesive Compositions which comprise a hydrophobic polymer wherein the concentration of the polymer at the surface of the adhesive is greater than its concentration in the bulk of the adhesive are described; and biomedical electrodes, fixation products and wound dressings containing them.Type: GrantFiled: October 29, 2002Date of Patent: July 11, 2006Assignee: First Water LimitedInventors: Hugh Semple Munro, Mohammed Yasin
-
Patent number: 7056526Abstract: The present invention provides a medical adhesive tape and a tape preparation for percutaneous absorption, both having an adhesive layer that resists glue remainder and stickiness upon peeling off of the tape even after adhesion to the human skin for a long time, and a medical adhesive composition to be used for such tapes. The medical adhesive composition of the present invention includes, as essential elements, (A) a copolymer containing (a) alkyl (meth)acrylate, wherein the alkyl moiety has 4 to 18 carbon atoms, in a proportion of not less than 50 wt % of the copolymer and (b) a carboxyl group-containing vinyl compound in a proportion of 0.1 wt %–10 wt % of the copolymer, (B) an alkoxide or a chelate compound of at least a metal selected from titanium, zirconium, zinc and aluminum, and (C) a polyol compound in a proportion of 0.2 wt %–5 wt % of the aforementioned medical adhesive composition.Type: GrantFiled: August 29, 2002Date of Patent: June 6, 2006Assignee: Nitto Denko CorporationInventors: Hidetoshi Kuroda, Takateru Muraoka, Keigo Inosaka, Hitoshi Akemi
-
Patent number: 7052714Abstract: Ophthalmic adhesive preparations for percutaneous absorption to be used in treating diseases in the posterior parts of eye characterized by having a drug-containing layer which contains a drug to be delivered to the posterior parts of eye including the crystalline lens, the vitreous body, the uvea and the retina, together with a percutaneous sorbefacient comprising polyoxyethylene oleyl ether and/or isopropyl myristate uniformly dispersed in a base matrix.Type: GrantFiled: September 29, 2000Date of Patent: May 30, 2006Assignees: Senju Pharmaceutical Co., LTD, Kakuji TojoInventors: Kakuji Tojo, Akiharu Isowaki
-
Patent number: 7037527Abstract: The invention features a method of treating polyester material to generate functional carboxylic acid and amine groups. These functional groups can be used as sites for covalent bond formation to attach chemical or biological moieties. This bifunctionalized polyester polymer can be used in any medical application in which biocompatible polymers are used.Type: GrantFiled: January 27, 2003Date of Patent: May 2, 2006Assignees: University of Rhode Island, Beth Israel Deaconess Medical Center, BioMod SurfacesInventors: Martin J. Bide, Matthew D. Phaneuf, William C. Quist, Donald J. Dempsey, Frank W. LoGerfo
-
Patent number: 7008647Abstract: The invention relates to the use of one or more antimicrobial metals selected from silver, gold, platinum, and palladium but most preferably silver, preferably formed with atomic disorder, and preferably in a nanocrystalline form, for the treatment of a acne. The nanocrystalline antimicrobial metal of choice may be used in the form of a nanocrystalline coating of one or more antimicrobial metals, a nanocrystalline powder of one or more antimicrobial metals, or a solution containing dissolved species from a nanocrystalline powder or coating of one or more antimicrobial metals.Type: GrantFiled: April 23, 2001Date of Patent: March 7, 2006Assignee: Nucryst Pharmaceuticals Corp.Inventors: Robert Edward Burrell, Hua Qing Yin
-
Patent number: 7001617Abstract: The invention relates to a method to induce apoptosis and to inhibit matrix metalloproteinases in a disease condition in a human or animal by contacting hyperplastic tissue, tumor tissue, or a cancerous lesion with one or more antimicrobial metals, preferably formed with atomic disorder, and preferably in a nanocrystalline form. In another aspect of the invention, there is provided a method of preventing excessive release of matrix metalloproteinases from an inflammatory cell in a disease condition in a human or an animal by contacting the cell with a therapeutically effective amount of a noble metal in a crystalline form characterized by atomic disorder, or with a solution derived therefrom to provide a modulatory effect on one or more matrix metalloproteinases, wherein the one or more noble metals is formed with atomic disorder, and preferably in a nanocrystalline form.Type: GrantFiled: May 30, 2002Date of Patent: February 21, 2006Assignee: Nueryst Pharmaceuticals Corp.Inventors: Robert Edward Burrell, John Barrymore Wright, Kan Lam
-
Patent number: 6987182Abstract: A dry hydrocolloid powder with cold-gel capabilities is produced by: dissolving a hydrocolloid comprising polysaccharide chains in an aqueous solution; heating the dissolved hydrocolloid solution to a temperature and for a time sufficient to induce a substantial alteration in the tertiary structure of the polysaccharide chains of the hydrocolloid; cooling the dissolved hydrocolloid solution to a temperature and for a time sufficient to substantially return the polysaccharide chains of the hydrocolloid to their original tertiary structure, wherein the polysaccharide chains form a gelling network; and drying the cooled hydrocolloid solution to form a dry powder. In some embodiments, the dry powder has a viscosity of between about 10 and 40 mPa-s when reconstituted in a 2% weight/weight solution at 25 degrees C. In other embodiments, the dry powder has a water absorption of greater than 20 g H2O/g powder.Type: GrantFiled: March 26, 2003Date of Patent: January 17, 2006Assignee: North Carolina State UniversityInventors: Jeffrey J. Resch, Christopher R. Daubert
-
Patent number: 6979454Abstract: A biologically active stick composition comprising a biologically active agent dissolved in a carrier system including an unsaturated fatty acid alcohol in mutual dissolution with an alkylene glycol as a solvent for said biologically active agent and a stiffening agent therefor, said stiffening agent imparting stick consistency to the composition, said alkylene glycol preferably being present in an amount of more than 12%. The composition can be prepared by dissolving the active agent in the solvent, combining the solution with the stiffening agent and shaping the formulation into a stick. The composition is especially intended for use as a medicament, preferably in the treatment of dermatological conditions, where it has been found to possess outstanding bioavailability properties.Type: GrantFiled: April 29, 1997Date of Patent: December 27, 2005Assignee: Jagotec AGInventors: Åke Lindahl, Rickard Bryland